Effects of oral sodium bicarbonate in patients with CKD

Clinical Journal of the American Society of Nephrology

Volumn 8, Issue 5, 2013, Pages 714-720

  Abramowitz, Matthew K ^a,b   Melamed, Michal L ^a,b   Bauer, Carolyn ^a   Raff, Amanda C ^a   Hostetter, Thomas H ^c  

^a Division of Nephrology   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BICARBONATE; CREATININE; NITROGEN; PLACEBO; POTASSIUM; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; ARTICLE; BLOATING; BLOOD PRESSURE; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; DRUG DOSE INCREASE; DYSPNEA; EDEMA; FEMALE; FLATULENCE; GASTROINTESTINAL SYMPTOM; HUMAN; MALE; METABOLIC ACIDOSIS; MUSCLE STRENGTH; NAUSEA; OUTCOME ASSESSMENT; PILOT STUDY; SINGLE BLIND PROCEDURE; WEIGHT GAIN; ACIDOSIS; AGED; BLOOD; CLINICAL TRIAL; CONVALESCENCE; DOSE RESPONSE; DRUG EFFECTS; HAND STRENGTH; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; RENAL INSUFFICIENCY, CHRONIC; SKELETAL MUSCLE; STATISTICAL MODEL; TIME; TREATMENT OUTCOME; UNITED STATES;

ACIDOSIS; ADMINISTRATION, ORAL; AGED; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HAND STRENGTH; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MUSCLE, SKELETAL; NEW YORK; PILOT PROJECTS; RECOVERY OF FUNCTION; RENAL INSUFFICIENCY, CHRONIC; SINGLE-BLIND METHOD; SODIUM BICARBONATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84877684620     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.08340812     Document Type: Article

References (37)

1. Moranne O, Froissart M, Rossert J, Gauci C, Boffa JJ, Haymann JP, M'rad MB, Jacquot C, Houillier P, Stengel B, Fouqueray B; NephroTest Study Group: Timing of onset of CKD-related metabolic complications. J Am Soc Nephrol 20: 164-171, 2009
2. de Brito-Ashurst I, Varagunam M, Raftery MJ, Yaqoob MM: Bicarbonate supplementation slows progression of CKD and improves nutritional status. J Am Soc Nephrol 20: 2075-2084, 2009
3. Kraut JA, Kurtz I: Metabolic acidosis of CKD: Diagnosis, clinical characteristics, and treatment. Am J Kidney Dis 45: 978-993, 2005
4. Shah SN, Abramowitz M, Hostetter TH, Melamed ML: Serum bicarbonate levels and the progression of kidney disease: A cohort study. Am J Kidney Dis 54: 270-277, 2009
5. Bailey JL, Wang X, England BK, Price SR, Ding X, Mitch WE: The acidosis of chronic renal failure activates muscle proteolysis in rats by augmenting transcription of genes encoding proteins of the ATP-dependent ubiquitin-proteasome pathway. J Clin Invest 97: 1447-1453, 1996
6. Bailey JL, Zheng B, Hu Z, Price SR, Mitch WE: Chronic kidney disease causes defects in signaling through the insulin receptor substrate/phosphatidylinositol 3-kinase/Akt pathway: Implications for muscle atrophy. J Am Soc Nephrol 17: 1388-1394, 2006
7. Ding H, Gao XL, Hirschberg R, Vadgama JV, Kopple JD: Impaired actions of insulin-like growth factor 1 on protein Synthesis and degradation in skeletal muscle of rats with chronic renal failure. Evidence for a postreceptor defect. J Clin Invest 97: 1064-1075, 1996
8. Fouque D, Peng SC, Kopple JD: Impaired metabolic response to recombinant insulin-like growth factor-1 in dialysis patients. Kidney Int 47: 876-883, 1995
9. Pickering WP, Price SR, Bircher G, Marinovic AC, Mitch WE, Walls J: Nutrition in CAPD: Serum bicarbonate and the ubiquitin-proteasome system in muscle. Kidney Int 61: 1286-1292, 2002
10. Heszele MF, Price SR: Insulin-like growth factor I: The yin and yang of muscle atrophy. Endocrinology 145: 4803-4805, 2004
11. Stein A, Moorhouse J, Iles-Smith H, Baker F, Johnstone J, James G, Troughton J, Bircher G, Walls J: Role of an improvement in acid-base status and nutrition in CAPD patients. Kidney Int 52: 1089-1095, 1997
12. Szeto CC, Wong TY, Chow KM, Leung CB, Li PK: Oral sodium bicarbonate for the treatment of metabolic acidosis in peritoneal dialysis patients: A randomized placebo-control trial. J Am Soc Nephrol 14: 2119-2126, 2003
13. Bossola M, Giungi S, Tazza L, Luciani G: Long-term oral sodium bicarbonate supplementation does not improve serum albumin levels in hemodialysis patients. Nephron Clin Pract 106: c51-c56, 2007
14. Brady JP, Hasbargen JA: Correction of metabolic acidosis and its effect on albumin in chronic hemodialysis patients. Am J Kidney Dis 31: 35-40, 1998
15. Williams AJ, Dittmer ID, McArley A, Clarke J: High bicarbonate dialysate in haemodialysis patients: Effects on acidosis and nutritional status. Nephrol Dial Transplant 12: 2633-2637, 1997
16. Hartmann EL, Kitzman D, Rocco M, Leng X, Klepin H, Gordon M, Rejeski J, Berry M, Kritchevsky S: Physical function in older candidates for renal transplantation: An impaired population. Clin J Am Soc Nephrol 4: 588-594, 2009
17. Padilla J, Krasnoff J, Da Silva M, Hsu CY, Frassetto L, Johansen KL, Painter P: Physical functioning in patients with chronic kidney disease. J Nephrol 21: 550-559, 2008
18. Devine BJ: Gentamicin therapy. Drug Intell Clin Pharm 8: 650-655, 1974
19. Csuka M, McCarty DJ: Simple method for measurement of lower extremity muscle strength. Am J Med 78: 77-81, 1985
20. Johansen KL, Mulligan K, Schambelan M: Anabolic effects of nandrolone decanoate in patients receiving dialysis: A randomized controlled trial. JAMA 281: 1275-1281, 1999
21. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration): A new equation to estimate glomerular filtration rate. Ann Intern Med 150: 604-612, 2009
22. Graham KA, Reaich D, Channon SM, Downie S, Goodship TH: Correction of acidosis in hemodialysis decreases whole-body protein degradation. J Am Soc Nephrol 8: 632-637, 1997
23. Reaich D, Channon SM, Scrimgeour CM, Goodship TH: Ammonium chloride-induced acidosis increases protein breakdown and amino acid oxidation in humans. Am J Physiol 263: E735-E739, 1992
24. Frassetto L, Morris RC, Sebastian A: Potassium bicarbonate reduces urinary nitrogen excretion in postmenopausal women. J Clin Endocrinol Metab 82: 254-259, 1997
25. Abramowitz MK, Hostetter TH, Melamed ML: Association of serum bicarbonate levels with gait speedand quadriceps strength in older adults. Am J Kidney Dis 58: 29-38, 2011
26. Zhou X, Loke KY, Pillai CC, How HK, Yap HK, Lee KO: IGFs and IGF-binding proteins in short children with steroid-dependent nephrotic syndrome on chronic glucocorticoids: Changes with 1 year exogenous GH. Eur J Endocrinol 144: 237-243, 2001
27. Gatenby VK, Kearney MT: The role of IGF-1 resistance in obesity and type 2 diabetes-mellitus-related insulin resistance and vascular disease. Expert Opin Ther Targets 14: 1333-1342, 2010
28. Wheatcroft SB, Kearney MT: IGF-dependent and IGF-in-dependent actions of IGF-binding protein-1 and -2: Implications for metabolic homeostasis. Trends Endocrinol Metab 20: 153-162, 2009
29. Mak RH: Effect of metabolic acidosis on insulin action and secretion in uremia. Kidney Int 54: 603-607, 1998
30. Reaich D, Graham KA, Channon SM, Hetherington C, Scrimgeour CM, Wilkinson R, Goodship TH: Insulin-mediated changes in PD and glucose uptake after correction of acidosis in humans with CRF. Am J Physiol 268: E121-E126, 1995
31. Brüngger M, Hulter HN, Krapf R: Effect of chronic metabolic acidosis on the growth hormone/IGF-1 endocrine axis: New cause of growth hormone insensitivity in humans. Kidney Int 51: 216-221, 1997
32. Headley S, Germain M, Mailloux P, Mulhern J, Ashworth B, Burris J, Brewer B, Nindl BC, Coughlin M, Welles R, Jones M: Resistance training improves strength and functional measures in patients with end-stage renal disease. Am J Kidney Dis 40: 355-364, 2002
33. Painter P, Carlson L, Carey S, Paul SM, My J: Physical functioning and health-related quality-of-life changes with exercise training in hemodialysis patients. Am J Kidney Dis 35: 482-492, 2000
34. National Kidney Foundation: K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42[Suppl 3]: S1-S201, 2003
35. Reaich D, Channon SM, Scrimgeour CM, Daley SE, Wilkinson R, Goodship TH: Correction of acidosis in humans with CRF decreases protein degradation and amino acid oxidation. Am J Physiol 265: E230-E235, 1993
36. Wesson DE, Simoni J, Broglio K, Sheather S: Acid retention accompanies reduced GFR in humans and increases plasma levels of endothelin and aldosterone. Am J Physiol Renal Physiol 300: F830-F837, 2011
37. Workeneh BT, Rondon-Berrios H, Zhang L, Hu Z, Ayehu G, Ferrando A, Kopple JD, Wang H, Storer T, Fournier M, Lee SW, Du J, Mitch WE: Development of a diagnostic method for detecting increased muscle protein degradation in patients with catabolic conditions. J Am Soc Nephrol 17: 3233-3239, 2006